Verus Capital Partners’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-771
Closed -$375K – 420
2025
Q2
$375K Sell
771
-106
-12% -$60.4K 0.03% 257
2025
Q1
$540K Buy
877
+15
+2% +$8.53K 0.05% 193
2024
Q4
$457K Buy
862
+4
+0.5% +$2.25K 0.04% 211
2024
Q3
$516K Sell
858
-80
-9% -$45.4K 0.05% 191
2024
Q2
$509K Sell
938
-185
-16% -$106K 0.05% 189
2024
Q1
$721K Buy
1,123
+16
+1% +$9.72K 0.08% 148
2023
Q4
$647K Buy
1,107
+8
+0.7% +$4.48K 0.08% 142
2023
Q3
$571K Buy
1,099
+50
+5% +$26K 0.08% 143
2023
Q2
$568K Sell
1,049
-28
-3% -$15.3K 0.08% 145
2023
Q1
$579K Buy
1,077
+100
+10% +$51K 0.09% 142
2022
Q4
$499K Buy
977
+25
+3% +$12.2K 0.09% 146
2022
Q3
$416K Buy
952
+50
+6% +$24K 0.08% 166
2022
Q2
$421K Sell
902
-40
-4% -$19.5K 0.08% 174
2022
Q1
$473K Buy
+942
New +$452K 0.07% 193
2020
Q1
$224K Buy
516
+59
+13% +$26.3K 0.07% 174
2019
Q4
$201K Buy
+457
New +$192K 0.07% 237

Other funds holding CHE

Verus Capital Partners's CHE Position: Q3 2025 in Review

Verus Capital Partners sold out of Chemed (CHE) in Q3 2025, closing a stake of 771 shares — an estimated $375K sold.

Verus Capital Partners first reported a position in CHE in Q4 2019 and held it in 16 quarters. The position peaked at $721K in Q1 2024. 523 funds tracked by Wall St. Rank hold CHE as of Q3 2025.

  • Verus Capital Partners reported no remaining Chemed position as of Q3 2025 after selling out during the quarter.
  • Verus Capital Partners sold 771 Chemed shares in Q3 2025, an estimated $375K.
  • Verus Capital Partners first reported a position in Chemed in Q4 2019 and held it in 16 quarters.
  • Verus Capital Partners's Chemed position peaked at $721K in Q1 2024.
  • 523 funds tracked by Wall St. Rank held Chemed as of Q3 2025.

Based on Verus Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.